The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predictors of benefit to radiation for oligoprogressive disease in EGFR-mutant metastatic non-small cell lung cancer patients treated with osimertinib.
 
Monica F Chen
Stock and Other Ownership Interests - Nordisk
 
Jennifer Ma
No Relationships to Disclose
 
Mark G. Kris
Consulting or Advisory Role - AstraZeneca; BerGenBio; Janssen; Merus; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Genentech
 
Daniel Richard Gomez
Honoraria - AstraZeneca; Bristol-Myers Squibb; GRAIL; Merck; Reflexion Medical; US Oncology; Varian Medical Systems; Vindico Medical Education
Consulting or Advisory Role - GRAIL; Johnson & Johnson/Janssen; Medtronic; Olympus Medical Systems
Research Funding - AstraZeneca; Bristol-Myers Squibb; Merck; Varian Medical Systems
Travel, Accommodations, Expenses - AstraZeneca; Driver, Inc; Merck; US Oncology; Varian Medical Systems; Vindico Medical Education
 
Helena Alexandra Yu
Consulting or Advisory Role - AstraZeneca; Black Diamond Therapeutics; Blueprint Medicines; C4 Therapeutics; Cullinan Oncology; Daiichi Sankyo; Janssen
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Blueprint Medicines; Cullinan Oncology (Inst); Daiichi Sankyo (Inst); Erasca, Inc (Inst); Janssen Oncology (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Lilly
Other Relationship - Astellas Pharma